The Board has determined that the veteran's death was caused by his service-connected conditions, including Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome, and Macrocytic Anemia, which were likely due to Agent Orange exposure during service. As such, the appeal for service connection for the cause of the veteran's death is granted.
The deciding factor: The Board found that the evidence was in relative equipoise regarding whether the veteran's conditions were caused by his service-connected conditions and Agent Orange exposure, thus granting the claim based on this finding.
- Claimed conditions
- Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome, Macrocytic Anemia
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- February 26, 2008
- Citation
- 0806361
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 0806361.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board has determined that the Veteran's cause of death, Acute Myelogenous Leukemia (AML), is related to his in-service exposure to herbicide agents. After considering all evidence and resolving all reasonable doubt in favor of the claimant, service connection for AML due to herbicide exposure is granted.
- Granted
The Veteran's service-connected disabilities render him unable to perform daily activities of living without the assistance of another, and he is granted special monthly compensation based on the need for regular aid and attendance.
- Partly granted
The Board denied service connection for various conditions and granted an initial 20 percent rating for right lower extremity deep vein thrombosis, while remanding several other issues.
- Remanded (sent back)
The Board has remanded several issues related to the effective dates and service connection for AML, including a motion to revise the November 2005 rating decision on CUE grounds. The propriety of the January 2022 rating decision regarding the effective date for accrued benefits purposes is also under review.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.